Am J Transplant, Volume 18, Suppl 3 Archives - Page 46 of 211 - ATC Abstracts

2018 American Transplant Congress
Measures of Physical Frailty, Cardiac Function and Cardiac Biomarkers among Kidney Transplant Candidates
S. Gilligan,¹ S. Anand,² D. Morris,² M. Minder,¹ T. Srinivas.²
¹Intermountain Medical Center, Murray, UT; ²University of Utah, Salt Lake City, UT.
Background: Elevated troponin T at transplant evaluation has been reported to confer risk of cardiovascular mortality among renal transplants. We use troponin T along with…
2018 American Transplant Congress
Portal Vein Thrombosis (PVT) in Liver Transplantation – Recent Experience
D. Bruce, H. Bohorquez, J. Seal, A. Cohen, E. Bugeaud, I. Carmody, D. Sonnier, A. Mathur, L. De Gregorio, H. Sharma, G. Loss.
Ochsner Multi-Organ Transplant Institute, Ochsner Medical Center, New Orleans, LA.
From 01-Nov-2012 to 31-Oct-2017, 1025 liver transplants were done at our center. Excluding retransplants and combined liver-kidney transplants, 830 transplants were studied for this abstract…
2018 American Transplant Congress
Dunbar Syndrome in Liver Transplantation: Results of a Single Center Matched-Pair Analysis and a European Survey Study
D. Morales-Santana,¹ Z. Czigany,¹ J. Böcker,¹ A. Andert,¹ W. Schöning,¹ T. Ulmer,¹ J. Bednarsch,¹ I. Amygdalos,¹ F. Meister,¹ P. Isfort,³ M. Liebl,³ D. Kroy,² F. Tacke,² C. Trautwein,² U. Neumann,¹ G. Lurje.¹
¹Department of Surgery and Transplantation, University Hospital RWTH, Aachen, Germany; ²Department of Internal Medicine III, University Hospital RWTH, Aachen, Germany; ³Institute of Radiology, University Hospital RWTH, Aachen, Germany.
Background: Median-arcuate-ligament or Dunbar-syndrome (MALs) potentially causes arterial complications in orthotopic liver transplantation (OLT). This study aimed to investigate MALs incidence and its impact on…
2018 American Transplant Congress
Survival Advantage from Accepting a Circulatory Death Liver Transplant
J. Richards,¹ R. Taylor,² E. Allen,² A. Goh,¹ J. Neuberger,³ D. Collett,² G. Pettigrew.¹
¹Department of Surgery, University of Cambridge, Cambridge, United Kingdom; ²Statistics and Clinical Studies, NHS Blood and Transplant, Bristol, United Kingdom; ³Department of Medicine, University of Birmingham, Birmingham, United Kingdom.
Background As liver failure increases in the UK, so does demand for liver transplantation. In response, UK donation after circulatory death (DCD) activity has approximately…
2018 American Transplant Congress
Impact of On-Site Overestimation of Macrosteatosis on Donor Liver Biopsy
M. Wright, J. Seal, L. De Gregorio, H. Bohorquez, D. Bruce, E. Bugeaud, I. Carmody, A. Mathur, D. Sonnier, G. Galliano, I. Oliva, L. Bratton, G. Loss.
Multi-Organ Transplant Institute, Ochsner Clinic Foundation, New Orleans.
Introduction: Estimation of hepatic steatosis is an important variable in determining suitability of a donor liver allograft for transplantation. Differentiation between and quantification of macro-…
2018 American Transplant Congress
Race/Ethnicity and Hypertension Self-Care Behaviors among US Living Kidney Donors
M. Johnson, T. Purnell, X. Luo, L. Cooper, M. Waldram, D. Crews, M. Henderson, A. Massie, D. Segev.
Johns Hopkins, Baltimore, MD.
Purpose: Despite the success of live donor kidney transplantation as an optimal treatment for ESRD, some living kidney donors may be at increased risk of…
2018 American Transplant Congress
Patient Change in Residence and Risk of Readmission after Renal Transplant in the US
J. Hogan, M. Anderson, Y. Zhang, J. Kim, G. Karadkhele, X. Zhang, A. Adams, R. Patzer.
Emory University, Atlanta, GA.
To predict readmission post-kidney transplant (KTX-R), novel risk factors must be identified. We investigated the impact of a) neighborhood (zipcode) and its attributes and b)…
2018 American Transplant Congress
Addressing the “Crisis” in Pancreas Transplant Volume Using a Multidisciplinary Approach
J. Scalea, S. Bartlett, R. Barth.
Surgery, University of Maryland, Baltimore, MD.
Background: Due in part to the recently revised pancreas allocation system, patients who are listed for simultaneous pancreas and kidney (SPK) transplantation can be transplanted…
2018 American Transplant Congress
Evaluation of MPA Dose on Development of DSA Following Pancreas Transplant
J. Descourouez,¹ M. Jorgenson,¹ A. Twigg,¹ G. Leverson,² J. Odorico,³ R. Redfield.³
¹Pharmacy, UW Health, Madison, WI; ²Surgery, UW Health, Madison, WI; ³Transplantation, UW Health, Madison, WI.
The relationship between mycophenolate (MPA) dose and the development of donor specific antibody (DSA) following pancreas transplant has not been elucidated. This study evaluates the…
2018 American Transplant Congress
Pancreatic Graft Loss after Simultaneous Pancreas Kidney (SPK) Transplant within First 90 Days. Predictors beyond the Surgical Cause. A UNOS/OPTN Data Analysis
H. Sharma, M. Abraham, J. Chen, D. Mikhail, S. Aquil, S. Patel, A. Skaro, V. McAlister, A. Sener, P. Luke.
Multi-Organ Transplantation Unit, University of Western Ontario, London, ON, Canada.
Background: Data on causal effects of variables to predict the early pancreatic graft loss in first 90 days is limited.Aim: To predict the early pancreatic…